Literature DB >> 2019220

Management of solitary pulmonary nodules.

G A Lillington1.   

Abstract

The solitary pulmonary nodule (SPN), a single intrapulmonary spherical lesion that is fairly well circumscribed, is a common clinical problem. About half of SPNs seen in clinical practice are malignant, usually bronchogenic carcinomas. Some nodules are primary tumors of other kinds or metastatic. Virtually all benign SPNs are tuberculous or fungal granulomas. The standard management of the SPN of unknown cause is prompt surgical removal unless benignity is established by prior chest roentgenograms showing that the nodule has been stable (i.e., showing no growth) for 2 years or by the presence of a "benign" pattern of calcification. Less universally accepted criteria for benignity include (1) transthoracic needle aspiration biopsy (TNAB) showing a specific benign process, and (2) patient's age under 30 to 35 years. Bronchoscopy has a low diagnostic yield, particularly for benign nodules. SPNs usually grow at constant rates, expressed as the "doubling time" (DT). A nodule with a DT between 20 and 400 days is usually malignant. Benign nodules usually have a DT greater than 400 days. The prospective determination of DT by serial chest roentgenograms (the "wait and watch" strategy) is widely criticized but has clinical utility in special circumstances, particularly if the likelihood of malignancy is low and/or the anticipated surgical mortality is high. The presence and pattern of calcification are best shown by high-resolution thin-section computed tomography (CT). Diffuse, laminated, central or "popcorn" patterns of calcification indicate benignity. An eccentric calcium deposit or a stippled pattern does not rule out malignancy. CT densitometry will often show "occult" calcification in nodules that show no direct visual evidence of calcium deposition. The characteristics of the edge of the nodule correlate with the likelihood of malignancy. Nodules with irregular or spiculated margins are almost always malignant. The probability that the nodule is malignant (pCA) is related to the age of the patient, the diameter of the nodule, the amount of tobacco smoke inhalation, the overall prevalence of malignancy in SPNs, the nature of the edge of the lesion, and the presence or absence of occult calcification. It is possible by Bayesian techniques to combine these factors to calculate a more precise and comprehensive prediction of pCA in any given nodule. The 5-year survival after nodule resection depends on the size of the nodule at the time of surgery; it may be as high as 80% with nodules that are 1 cm in diameter. Lymph node involvement is uncommon with small tumors, and many authorities question the need for CT staging in such cases.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 2019220     DOI: 10.1016/s0011-5029(05)80012-4

Source DB:  PubMed          Journal:  Dis Mon        ISSN: 0011-5029            Impact factor:   3.800


  24 in total

1.  Long-term follow-up of non-calcified pulmonary nodules (<10 mm) identified during low-dose CT screening for lung cancer.

Authors:  Michael M Slattery; Claire Foley; Dermot Kenny; Richard W Costello; P Mark Logan; Michael J Lee
Journal:  Eur Radiol       Date:  2012-04-27       Impact factor: 5.315

Review 2.  [Video-assisted diagnostic thoracoscopy].

Authors:  T Bergmann; S Bölükbas; S Beqiri; J Schirren
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

3.  Video-assisted thoracoscopic resection of a small pulmonary nodule after computed tomography-guided localization with a hook-wire system. Experience in 45 consecutive patients.

Authors:  Olivier Pittet; Michel Christodoulou; Edgardo Pezzetta; Sabine Schmidt; Pierre Schnyder; Hans-Beat Ris
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

4.  The value of BAL fluid LDH level in differentiating benign from malignant solitary pulmonary nodules.

Authors:  Ali Emad; Vahid Emad
Journal:  J Cancer Res Clin Oncol       Date:  2007-09-20       Impact factor: 4.553

5.  Solitary pulmonary nodules and masses: a meta-analysis of the diagnostic utility of alternative imaging tests.

Authors:  Paul Cronin; Ben A Dwamena; Aine Marie Kelly; Steven J Bernstein; Ruth C Carlos
Journal:  Eur Radiol       Date:  2008-07-08       Impact factor: 5.315

6.  The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules.

Authors:  Hiren J Mehta; James G Ravenel; Stephanie R Shaftman; Nichole T Tanner; Luca Paoletti; Katherine K Taylor; Martin C Tammemagi; Mario Gomez; Paul J Nietert; Michael K Gould; Gerard A Silvestri
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

7.  Quantitative MDCT analysis of pulmonary solid nodules using three parameters.

Authors:  Naoki Kutuya; Yutaka Ozaki; Yoshihisa Kurosaki
Journal:  Radiat Med       Date:  2008-09-04

8.  A case of haemoptysis due to endobrnchial fibroma, a rare benign tumour of lung.

Authors:  Sibes Kumar Das; Ramendra Sundar Mukherjee; Anirban Das; Amp Kumar Halder; Samirendra Kumar Saha
Journal:  Lung India       Date:  2008-01

9.  Does the availability of positron emission tomography modify diagnostic strategies for solitary pulmonary nodules? An observational study in France.

Authors:  Irawati Lemonnier; Cédric Baumann; Nicolas Jay; Kazem Alzahouri; Patrick Arveux; Damien Jolly; Catherine Lejeune; Michel Velten; Fabien Vitry; Marie-Christine Woronoff-Lemsi; Francis Guillemin
Journal:  BMC Cancer       Date:  2009-05-11       Impact factor: 4.430

10.  Volumetric measurement of pulmonary nodules at low-dose chest CT: effect of reconstruction setting on measurement variability.

Authors:  Ying Wang; Geertruida H de Bock; Rob J van Klaveren; Peter van Ooyen; Wim Tukker; Yingru Zhao; Monique D Dorrius; Rozemarijn Vliegenthart Proença; Wendy J Post; Matthijs Oudkerk
Journal:  Eur Radiol       Date:  2009-11-18       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.